Streetbeat News

Regulatory

HOOD

Dan Gallagher, Robinhood's Chief Legal Officer, is considered a leading candidate to head the SEC if Trump wins the presidency, according to former regulators and securities lawyers.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 1:30 pm

HIMS

Hims & Hers Health Inc (NYSE:HIMS) shares are rising as the company is set to join the S&P SmallCap 600, replacing Vector Group. The stock had previously fallen due to FDA's removal of Eli Lilly's drugs from the shortage list, affecting Hims & Hers' compounded drug sales.

Portfolio Pulse from Adam Eckert

October 07, 2024 | 1:17 pm

BMEA

Biomea Fusion will present data from its COVALENT-111 and COVALENT-112 diabetes clinical trials at the ATTD-ASIA 2024 conference. The presentations will focus on the investigational drug BMF-219, a menin inhibitor aimed at regenerating insulin-producing beta cells.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 1:09 pm

KRON

Kronos Bio has announced the selection of KB-7898, a p300 KAT inhibitor, as a development candidate for Sjögren's disease. Preclinical data will be presented at ACR Convergence 2024, with IND-enabling studies planned for Q4 2024. KB-7898 is Kronos Bio's first autoimmune disease candidate.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:57 pm

KZR

The FDA has placed a clinical hold on Kezar Life Sciences' mid-stage study of zetomipzomib for lupus nephritis following patient deaths. The company had already suspended the trial based on safety concerns. Kezar's other trials remain unaffected.

Portfolio Pulse from Vandana Singh

October 07, 2024 | 12:50 pm

BFRI

Biofrontera has received FDA approval for its supplemental New Drug Application (sNDA) to increase the maximum approved dosage of Ameluz topical gel from one to three tubes per treatment. This approval could potentially enhance the product's marketability and sales.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:46 pm

AMPG

AmpliTech Group has been granted a patent by the US Patent and Trademark Office for technology related to 5G and cryogenic applications in quantum computing. This development could enhance their technological capabilities and market position.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:34 pm

LKCO

Luokung Technology Corp. has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the exchange. This development is crucial for maintaining investor confidence and access to capital markets.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 12:30 pm

BTCUSD

ETHUSD

Mark Cuban criticizes SEC Chair Gary Gensler for complex crypto regulations, suggesting a simpler approach like Japan's could have prevented collapses like FTX. Cuban argues current policies hinder crypto growth and supports pro-crypto figures like John Deaton.

Portfolio Pulse from Pooja Rajkumari

October 07, 2024 | 12:30 pm

SPY

A report by the Committee for a Responsible Federal Budget indicates that Trump's proposals could increase US debt by $7.5 trillion, while Harris' could add $3.5 trillion by 2035. Both candidates lack plans to address the debt crisis. The SPDR S&P 500 ETF Trust (SPY) fell 0.45% in premarket trading.

Portfolio Pulse from Shanthi Rexaline

October 07, 2024 | 12:21 pm